Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Breast Carcinoma In Situ

• Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
• Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
• Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
• Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
• Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ
• Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
• Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
• Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
• Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
• Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
• Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
• Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
• Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
• Oxybutynin Chloride in Managing Hot Flashes
• Ruxolitinib for Premalignant Breast Disease
• The PROMISE Study: Duavee in Women With DCIS
• Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
• Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
• MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
• Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
• Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
• Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
• Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
• Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
• Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
• Broccoli Sprout Extract in Treating Patients With Breast Cancer
• "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
• Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
• Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
• Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
• 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
• A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
• Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
• Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
• Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast